Cynthia Smith

Chief Commercial Officer, ZS Pharma, Inc.

Companies

Tvardi Therapeutics, Inc.Board member Apr 17, 2025 to now¹
Agios PharmaceuticalsBoard member Aug 15, 2022 to now²
Proteon TherapeuticsBoard member Feb 1, 2021 to now³
Spero Therapeutics, Inc.Board member Mar 19, 2019 to now⁴
Akebia Therapeutics, Inc.Board member Aug 29, 2018 to now⁵
Dicerna Pharmaceuticals (United States)Board member Aug 15, 2018 to Dec 29, 2021⁶
Alpine Immune SciencesBoard member Nov 4, 2016 to Nov 4, 2016⁷

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jun 23, 2026Granted 10,000 shares of Spero Therapeutics, Inc.¹⁰
Jun 18, 2026Exercised options 2,816 shares of Agios Pharmaceuticals⁸
Jun 17, 2026Granted 35,700 shares of Akebia Therapeutics, Inc.⁹
Aug 11, 2025Exercised options 2,302 shares of Agios Pharmaceuticals¹²
Jun 20, 2025Exercised options 2,120 shares of Agios Pharmaceuticals¹³
Jun 12, 2025Granted 20,000 shares of Spero Therapeutics, Inc.¹⁴
Jun 10, 2025Granted 35,700 shares of Akebia Therapeutics, Inc.¹⁵
Aug 11, 2024Exercised options 2,302 shares of Agios Pharmaceuticals¹⁶
Jun 13, 2024Exercised options 3,388 shares of Agios Pharmaceuticals¹⁷
Jun 6, 2024Granted 30,000 shares of Akebia Therapeutics, Inc.¹⁸
May 29, 2024Granted 20,000 shares of Spero Therapeutics, Inc.¹⁹
Oct 5, 2023Granted 20,000 shares of Spero Therapeutics, Inc.²⁰
Aug 11, 2023Exercised options 2,302 shares of Agios Pharmaceuticals²¹
Jun 6, 2023Granted 30,000 shares of Akebia Therapeutics, Inc.²²
Sep 15, 2022Granted 15,000 shares of Spero Therapeutics, Inc.²³
Jun 8, 2022Granted 13,700 shares of Akebia Therapeutics, Inc.²⁴
Dec 28, 2021U 3,333 shares at $38.25 of Dicerna Pharmaceuticals (United States)¹¹

The numbers on this page point here. Each one links to the record it came from.